Hilltop National Bank’s Fate Therapeutics FATE Stock Holding History

Hilltop National Bank’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$770	Hold	285	–	–	﹤0.01%	785
2026 Q1	$342	Hold	285	–	–	﹤0.01%	786
2025 Q4	$280	Hold	285	–	–	﹤0.01%	772
2025 Q3	$359	Hold	285	–	–	﹤0.01%	779
2025 Q2	$319	Buy	+285	New	+$331	﹤0.01%	779
2024 Q4	$470	Hold	285	–	–	﹤0.01%	759
2024 Q3	$998	Hold	285	–	–	﹤0.01%	792
2024 Q2	$935	Hold	285	–	–	﹤0.01%	793
2024 Q1	$2.09K	Buy	+285	New	+$1.76K	﹤0.01%	747

Other funds holding FATE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

NCM

Narwhal Capital Management Marietta, Georgia $1.45B AUM 28.39% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

OCWP

Owl Creek Wealth Partners Denver, Colorado $342M AUM

Hilltop National Bank's FATE Position: Q2 2026 in Review

Hilltop National Bank held its Fate Therapeutics (FATE) position steady in Q2 2026 at 285 shares worth $770. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Hilltop National Bank first reported a position in FATE in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.09K in Q1 2024. 21 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

Hilltop National Bank held 285 shares of Fate Therapeutics worth $770 as of Q2 2026.
Hilltop National Bank left its Fate Therapeutics share count unchanged in Q2 2026.
Fate Therapeutics made up ﹤0.01% of Hilltop National Bank's portfolio in Q2 2026, its #785 holding.
Hilltop National Bank first reported a position in Fate Therapeutics in Q1 2024 and has held it in 9 quarters since.
Hilltop National Bank's Fate Therapeutics position peaked at $2.09K in Q1 2024.
21 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.